AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review Post author:GIBoardReview.com Post published:December 29, 2023 Post category:Society Guidelines You Might Also Like AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease September 29, 2023 AGA Clinical Practice Update on Endoscopic Enteral Access: Commentary December 20, 2024 AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies for Select Gastrointestinal Diseases March 8, 2024
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease September 29, 2023
AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies for Select Gastrointestinal Diseases March 8, 2024
